Menu
Back to Journals » ImmunoTargets and Therapy » Volume 13
Original Research
Survival Benefit of Synchronous Lenvatinib Combined PD-1 Inhibitors for Advanced Hepatocellular Carcinoma Beyond Oligometastasis
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 441 | Dovepress* | 441+ | 10 | 451 | |
| Totals | 441 | 10 | 451 | ||
| *Since 17 June 2024 | |||||
View citations on PubMed Central and Google Scholar